Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-05-07

FDA Approved: OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION — Supplemental Application (Gland Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for olopatadine hydrochloride ophthalmic solution from Gland Pharma Limited, indicating an updated or expanded approval …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION (olopatadine hydrochloride ophthalmic solution)

Snippet

SUPPL AP for OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION (OLOPATADINE HYDROCHLORIDE OPHTHALMIC)